NCT05136547View on ClinicalTrials.gov

Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database

CompletedOBSERVATIONAL
Enrollment

2,927

Participants

Timeline

Start Date

January 6, 2022

Primary Completion Date

May 16, 2022

Study Completion Date

May 16, 2022

Conditions
Asthma
Trial Locations (1)

Unknown

Research Site, Tokyo

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY